Differences in reported survival outcomes can be attributed to patient-specific factors, such as sex, age, and NF1 status, and tumor-related factors, such as size, location, grade, genetics, systemic treatment, and extent of surgical resection. This evidence concerns the gene NF1 and neoplasm.